Cargando…
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
BACKGROUND: Fourteen-membered ring macrolides have been effective in reducing chronic airway inflammation and also preventing lung injury and fibrosis in bleomycin-challenged mice via anti-inflammatory effects. EM703 is a new derivative of erythromycin (EM) without the bactericidal effects. We inves...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434738/ https://www.ncbi.nlm.nih.gov/pubmed/16438734 http://dx.doi.org/10.1186/1465-9921-7-16 |
_version_ | 1782127242990583808 |
---|---|
author | Li, Ying Ji Azuma, Arata Usuki, Jiro Abe, Shinji Matsuda, Kuniko Sunazuka, Toshiaki Shimizu, Takako Hirata, Yukiyo Inagaki, Hirofumi Kawada, Tomoyuki Takahashi, Satoru Kudoh, Shoji Omura, Satoshi |
author_facet | Li, Ying Ji Azuma, Arata Usuki, Jiro Abe, Shinji Matsuda, Kuniko Sunazuka, Toshiaki Shimizu, Takako Hirata, Yukiyo Inagaki, Hirofumi Kawada, Tomoyuki Takahashi, Satoru Kudoh, Shoji Omura, Satoshi |
author_sort | Li, Ying Ji |
collection | PubMed |
description | BACKGROUND: Fourteen-membered ring macrolides have been effective in reducing chronic airway inflammation and also preventing lung injury and fibrosis in bleomycin-challenged mice via anti-inflammatory effects. EM703 is a new derivative of erythromycin (EM) without the bactericidal effects. We investigated the anti-inflammatory and antifibrotic effects of EM703 in an experimental model of bleomycin-induced lung injury and subsequent fibrosis in mice. METHODS: Seven-week-old male ICR mice were used. All experiments used eight mice/group, unless otherwise noted in the figure legends. Bleomycin was administered intravenously to the mice on day 0. EM703 was orally administered daily to mice. All groups were examined for cell populations in the bronchoalveolar lavage (BAL) fluid and for induction of messenger RNA (mRNA) of Smad3 and Smad4 in the lung tissues by reverse transcriptase (RT)-polymerase chainreaction (PCR) on day 7. Fibroblastic foci were assessed histologically, and the hydroxyproline content was chemically determined in the lung tissues on day 28. We performed assay of proliferation and soluble collagen production, and examined the induction of mRNA of Smad3 and Smad4 by RT-PCR in murine lung fibroblast cell line MLg2908. We also examined Smad3, Smad4 and phosphorylated Smad2/3 (p-Smad2/3) protein assay by western blotting in MLg2908. RESULTS: Bleomycin-induced lung fibrosis, and the infiltration of macrophages and neutrophils into the airspace were inhibited by EM703. The expression of Smad3 and Smad4 mRNA was clearly attenuated by bleomycin, but was recovered by EM703. EM703 also inhibited fibroblast proliferation and the collagen production in lung fibroblasts induced by Transforming growth factor-beta (TGF-β). The expression of Smad3 and Smad4 mRNA in murine lung fibroblasts disappeared due to TGF-β, but was recovered by EM703. EM703 inhibited the expression of p-Smad2/3 and Smad4 protein in murine lung fibroblasts induced by TGF-β. CONCLUSION: These findings suggest that EM703 improves bleomycin-induced pulmonary fibrosis in mice by actions of anti-inflammation and regulation of TGF-β signaling in lung fibroblasts. |
format | Text |
id | pubmed-1434738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-14347382006-04-08 EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts Li, Ying Ji Azuma, Arata Usuki, Jiro Abe, Shinji Matsuda, Kuniko Sunazuka, Toshiaki Shimizu, Takako Hirata, Yukiyo Inagaki, Hirofumi Kawada, Tomoyuki Takahashi, Satoru Kudoh, Shoji Omura, Satoshi Respir Res Research BACKGROUND: Fourteen-membered ring macrolides have been effective in reducing chronic airway inflammation and also preventing lung injury and fibrosis in bleomycin-challenged mice via anti-inflammatory effects. EM703 is a new derivative of erythromycin (EM) without the bactericidal effects. We investigated the anti-inflammatory and antifibrotic effects of EM703 in an experimental model of bleomycin-induced lung injury and subsequent fibrosis in mice. METHODS: Seven-week-old male ICR mice were used. All experiments used eight mice/group, unless otherwise noted in the figure legends. Bleomycin was administered intravenously to the mice on day 0. EM703 was orally administered daily to mice. All groups were examined for cell populations in the bronchoalveolar lavage (BAL) fluid and for induction of messenger RNA (mRNA) of Smad3 and Smad4 in the lung tissues by reverse transcriptase (RT)-polymerase chainreaction (PCR) on day 7. Fibroblastic foci were assessed histologically, and the hydroxyproline content was chemically determined in the lung tissues on day 28. We performed assay of proliferation and soluble collagen production, and examined the induction of mRNA of Smad3 and Smad4 by RT-PCR in murine lung fibroblast cell line MLg2908. We also examined Smad3, Smad4 and phosphorylated Smad2/3 (p-Smad2/3) protein assay by western blotting in MLg2908. RESULTS: Bleomycin-induced lung fibrosis, and the infiltration of macrophages and neutrophils into the airspace were inhibited by EM703. The expression of Smad3 and Smad4 mRNA was clearly attenuated by bleomycin, but was recovered by EM703. EM703 also inhibited fibroblast proliferation and the collagen production in lung fibroblasts induced by Transforming growth factor-beta (TGF-β). The expression of Smad3 and Smad4 mRNA in murine lung fibroblasts disappeared due to TGF-β, but was recovered by EM703. EM703 inhibited the expression of p-Smad2/3 and Smad4 protein in murine lung fibroblasts induced by TGF-β. CONCLUSION: These findings suggest that EM703 improves bleomycin-induced pulmonary fibrosis in mice by actions of anti-inflammation and regulation of TGF-β signaling in lung fibroblasts. BioMed Central 2006 2006-01-27 /pmc/articles/PMC1434738/ /pubmed/16438734 http://dx.doi.org/10.1186/1465-9921-7-16 Text en Copyright © 2006 Li et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Li, Ying Ji Azuma, Arata Usuki, Jiro Abe, Shinji Matsuda, Kuniko Sunazuka, Toshiaki Shimizu, Takako Hirata, Yukiyo Inagaki, Hirofumi Kawada, Tomoyuki Takahashi, Satoru Kudoh, Shoji Omura, Satoshi EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts |
title | EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts |
title_full | EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts |
title_fullStr | EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts |
title_full_unstemmed | EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts |
title_short | EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts |
title_sort | em703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of tgf-β signaling in lung fibroblasts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434738/ https://www.ncbi.nlm.nih.gov/pubmed/16438734 http://dx.doi.org/10.1186/1465-9921-7-16 |
work_keys_str_mv | AT liyingji em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT azumaarata em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT usukijiro em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT abeshinji em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT matsudakuniko em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT sunazukatoshiaki em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT shimizutakako em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT hiratayukiyo em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT inagakihirofumi em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT kawadatomoyuki em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT takahashisatoru em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT kudohshoji em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts AT omurasatoshi em703improvesbleomycininducedpulmonaryfibrosisinmicebytheinhibitionoftgfbsignalinginlungfibroblasts |